Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing’s syndrome

Pituitary

Volumn 18, Issue 1, 2015, Pages 135-141

  Barahona, María José ^a,c   Resmini, Eugenia ^b,c   Viladés, David ^b   Fernández Real, José Manuel ^d   Ricart, Wifredo ^d   Moreno Navarrete, José María ^d   Pons Lladó, Guillem ^b   Leta, Rubén ^b   Webb, Susan M ^b,c  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Adipokines; Atherosclerosis; Coronary calcifications; Cushing s syndrome

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; INSULIN; INTERLEUKIN 6; LIPOPROTEIN A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGATSTON SCORE; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CUSHING SYNDROME; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC PARAMETERS; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE; CALCINOSIS; CASE CONTROL STUDY; CORONARY BLOOD VESSEL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADULT; ATHEROSCLEROSIS; BLOOD PRESSURE; CALCINOSIS; CASE-CONTROL STUDIES; CORONARY VESSELS; CUSHING SYNDROME; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TRIGLYCERIDES;

EID: 84939416250     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-014-0566-9     Document Type: Article

References (28)

1. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filipella M, Di Somma C, Lombardi G, Colao A (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527–2533
2. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filipella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664–2672
3. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G (2004) High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 61:768–777
4. Pivonello R, Faggiano A, Lombardi G, Colao A (2005) The metabolic syndrome and cardiovascular risk in Cushing’s syndrome. Endocrinol Metab Clin North Am 34:327–339
5. Barahona MJ, Sucunza N, Resmini E, Fernández-Real JM, Ricart W, Moreno-Navarrete JM, Puig T, Farrerons J, Webb SM (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab 94:3365–3371
6. Fallo F, Famoso G, Capizzi D, Sonino N, Dassie F, Maffei P, Martini C, Paoletta A, Iliceto S, Tona F (2013) Coronary microvascular function in patients with Cushing’s syndrome. Endocrine 43:206–213
7. Neary NM, Booker OJ, Abel BS, Matta JR, Muldoon N, Sinaii N, Pettigrew RI, Nieman LK, Gharib AM (2013) Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography. J Clin Endocrinol Metab 98:2045–2052
8. Barahona MJ, Resmini E, Viladés D, Pons-Lladó G, Leta R, Puig T, Webb SM (2013) Coronary artery disease detected by multislice computed tomography in patients alter long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab 98:1093–1099
9. Thilo C, Standl E, Knez A, Reiser M, Steinbeck G, Haberl R, Schnell O (2004) Coronary calcification in long-term type 1 diabetic patients—a study with multi slice spiral computed tomography. Exp Clin Endocrinol Diabetes 112:561–565
10. Becker A, Knez A, Leber A, Boekstegers P, Steinbeck G (2004) Diabetes mellitus type 2: coronary calcifications as a predictor of coronary artery disease. Herz 29:488–495
11. Cannavo S, Almoto B, Cavalli G, Squadrito S, Romanello G, Vigo MT, Fiumara F, Benvenga S, Trimarchi F (2006) Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography. J Clin Endocrinol Metab 91:3766–3772
12. Bogazzi F, Battolla L, Spinelli C, Rossi G, Gavioli S, Di Bello V, Cosci C, Sardella C, Volterrani D, Talini E, Pepe P, Falaschi F, Mariani G, Martino E (2007) Risk factors for development of coronary heart disease in patients with acromegaly: a 5-year prospective study. J Clin Endocrinol Metab 92:4271–4277
13. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426–1433
14. Fernández-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C (1998) Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47:1757–1762
15. Santaniemi M, Kesäbuenu YA, Ukkola O (2006) Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 155:745–750
16. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B (2007) Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92:571–576
17. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M (2003) Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108:2317–2322
18. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599–2610
19. Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O’Gara P, Rubin GD (2010) Appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation appropriate use criteria task force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 56:1864–1894
20. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832
21. Leta R, Carreras F, Alomar X, Monell J, García-Picart J, Augé JM, Salvador A, Pons-Lladó G (2004) Non-invasive coronary angiography with 16 multidetector-row spiral computed tomography: a comparative study with invasive coronary angiography. Rev Esp Cardiol 57:217–224
22. Church TS, Levine BD, McGuire DK, LaMonte MJ, FitzGerald SJ, Cheng YJ, Kimball TE, Blair SN, Gibbons LW, Nichaman MZ (2007) Coronary artery calcium score, risk factors, and incident coronary heart disease events. Atherosclerosis 190:224–231
23. Keelan PC, Bielak LF, Ashai K, Jamjoum LS, Denktas AE, Rumberger JA, Sheedy PF, Peyser PA, Schwartz RS (2001) Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 104:412–417
24. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K (2003) Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5,635 initially asymptomatic low- to intermediate-risk adults. Circulation 107:2571–2576
25. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffmann U, Cury RC, Abbara S, Brady TJ, Budoff MJ, Blumenthal RS, Nasir K (2009) Diagnostic and prognostic value of absence of coronary artery calcification. J Am Coll Cardiol Img 2:675–688
26. Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegard J (2003) Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 48:2533–2540
27. Al-Aly Z (2008) Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res 151:233–239
28. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJW, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines T, Berman DS, for the CONFIRM Investigators (2011) Age and sex-related differences in all cause mortality risk based on coronary computed tomography angiography findings. Results from the international multicenter CONFIRM (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 58:849–860